Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia

Lee S et al. Ann Hematol, May 2026 (epub ahead of print)

• Share
• Tweet
• Share
• Share